News | Stroke | September 09, 2026

New Research Links Increased Stroke Risk to Cancer Diagnosis

Study reveals a higher ischemic stroke risk within three months of a cancer diagnosis, especially for pancreatic and lung cancers.

New Research Links Increased Stroke Risk to Cancer Diagnosis

Image: Getty Images/peterscheiber.media


Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke, especially in the first few months after diagnosis and especially if they have certain types of cancer. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Although multiple studies have demonstrated a link between cancer and stroke risk, specifics related to timing and cancer types are unclear. To investigate, researchers analyzed information from two registries in Israel: the Israel National Cancer Registry and the Israel National Stroke Registry.

Ischemic Stroke Risk

The team assessed the incidence of new ischemic strokes within 1 year of diagnosis among 182,221 adults aged ≥40 years who were diagnosed with a first invasive cancer in 2014–2021. Overall, there were 80% more strokes in patients with cancer than expected based on information from the general population, with 62 out of every 10,000 patients experiencing a stroke. Risk peaked during the first 3 months after diagnosis, when patients had a 2.5-times higher stroke rate than expected. The highest stroke rates occurred in patients with pancreatic cancer (a 5.9-times higher rate than expected, with 162 out of every 10,000 patients) and lung cancer (a 3.9-times higher rate). Breast and prostate cancers were not linked to a higher risk of stroke. Compared with the general population, stroke risk appeared to be especially elevated in younger patients and those with advanced cancer.

“Our findings identify the first months after a cancer diagnosis as a critical window of heightened ischemic stroke risk,” said corresponding author Carmit Libruder, MSc, of the University of Haifa and the Israel Ministry of Health. “The marked variation across cancer types, with particularly pronounced risk elevations in pancreatic and lung cancers, highlights the importance of identifying patients who may benefit from closer cerebrovascular risk assessment.”

Reference

  1. “Elevated Risk of Ischemic Stroke After Invasive Cancer Diagnosis: A Nationwide Population-Based Study.” Carmit Libruder, David Tanne, Barbara Silverman, Binyamin Binyaminy, Rita Dichtiar, and Lital Keinan-Boker. CANCER; Published Online: September 8, 2026 (DOI: 10.1002/cncr.70536).
     

Stroke Cancer Link

 


Related Content

News | Cardiovascular Clinical Studies

Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...

Home September 02, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had ...

Home August 21, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...

Home August 06, 2026
Home
News | Cardiovascular Clinical Studies

June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...

Home June 25, 2026
Home
News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
Subscribe Now